Inhaled corticosteroids may have a beneficial effect on bone metabolism in newly diagnosed asthmatic children

Pulmonary Pharmacology and Therapeutics

Volumn 24, Issue 4, 2011, Pages 414-420

  Stelmach, Iwona ^a   Olszowiec Chlebna, Malgorzata ^a   Jerzynska, Joanna ^a   Grzelewski, Tomasz ^a   Stelmach, Włodzimierz ^a   Majak, Pawel ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma; Bone metabolism; Children; Inhaled corticosteroids; Vitamin D

Indexed keywords

ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; BUDESONIDE; CALCIFEDIOL; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; COLECALCIFEROL; MONTELUKAST; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BONE DEFECT; BONE METABOLISM; CALCIUM BLOOD LEVEL; CHILD; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

ACETATES; ADMINISTRATION, INHALATION; ADOLESCENT; ASTHMA; BONE AND BONES; BUDESONIDE; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; PARATHYROID HORMONE; PHOSPHORUS; QUINOLINES;

EID: 79956123762     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.01.004     Document Type: Article

References (30)

1. Global Strategy for asthma management and prevention. Global initiative for asthma, Global Initiative for asthma (GINA) 2006, available at, [accessed 16.10.07.]. http://www.ginasthma.org.
2. Bacharier L.B., Boner A., Carlsen K.H., Eigenmann P.A., Frischer T., Götz M., et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008, 63:5-34.
3. Canalis E., Delany A.M. Mechanism of glucocorticoid action on bone. Ann NY Acad Sci 2002, 966:73-81.
4. van Staa T.P., Cooper C., Leufkens H.G., Bishop N. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003, 18:913-918.
5. Mortimer K.J., Harrison T.W., Tattersfield A.E. Effects of inhaled corticosteroids on bone. Ann Allergy Asthma Immunol 2005, 94:15-21.
6. Rizzo M.C., Sole D. Inhaled corticosteroids in the treatment of respiratory allergy: safety vs. efficacy. J Pediatr (Rio J) 2006, 82:198-205.
7. Pedersen S. Do inhaled corticosteroids inhibit growth in children?. Am J Respir Crit Care Med 2001, 164:521-535.
8. Bartkowiak-Emeryk M., Breogonekbowicz A., Emeryk A., Kulus M., Kurzawa R., Lis G., et al. Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children. Pol Merkur Lekarski 2004, 17:12-18.
9. Fares J.E., Choucair M., Nabulsi M., Salamoun M., Shahine C.H. Fuleihan Gel-H. Effect of gender, puberty, and vitamin D status on biochemical markers of bone remodedeling. Bone 2003, 33:242-247.
10. Reilly S.M., Hambleton G., Adams J.E., Mughul M.Z. Bone density in asthmatic children treated with inhaled corticosteroids. Arch Dis Child 2001, 84:183.
11. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001, 44:1496-1503. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
12. Searing D.A., Zhang Y., Murphy J.R., Hauk P.J., Goleva E., Leung D.Y. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol 2010, 125:995-1000.
13. Brehm J.M., Schuemann B., Fuhlbrigge A.L., Hollis B.W., Strunk R.C., Zeiger R.S., et al. Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management program study. J Allergy Clin Immunol 8 Jun 2010, [Epub ahead of print].
14. Skinner E.A., Diette G.B., Algatt-Bergstrom P.J., Nguyen T.T., Clark R.D., Markson L.E. The asthma therapy assessment questionnaire (ATAQ) for children and adolescents. Dis Manag 2004, 7:305-313.
15. Pedersen S., Warner J., Wahn U., Staab D., Le Bourgeois M., Van Essen-Zandvliet E., et al. Growth, systemie safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children. Pediatrics 2002, 109:e92.
16. Griffiths A.L., Sim D., Strauss B., Rodda C., Amstrong D., Freezer N. Effect of high-dose fluticasone propionate on bone density and metabolism in children with asthma. Pediatr Pulmonol 2004, 37:116-121.
17. Kelly H.W., Strunk R.C., Donithan M., Bloomberg G.R., McWilliams B.C., Szefler S. Growth and bone density in children with mild-moderate asthma: a cross-sectional study in children entering the childhood asthma management program (CAMP). J Pediatr 2003, 142:286-291.
18. Jones A., Fay J.K., Burr M., Stone M., Hood K., Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002, 1:CD003537.
19. Allen H.D., Thong I.G., Clifton-Bligh P., Holmes S., Nery L., Wilson K.B. Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 2000, 29:188-193.
20. Kannisto S., Korppi M., Arikoski P., Remes K., Voutilainen R. Biochemical markers of bone metabolism in relation to adrenocortical and growth suppression during the initiation phase of inhaled steroid therapy. Pediatr Res 2002, 52:258-262.
21. Crowley S., Trivedi P., Risteli L., Risteli J., Hindmarsh P.C., Brook C.G. Collagen metabolism and growth in prepubertal children with asthma treated with inhaled steroids. J Pediatr 1998, 132:409-413.
22. Allen D.B. Effects of inhaled steroids on growth, bone metabolism, and adrenal function. Adv Pediatr 2006, 53:101-110.
23. Agertoft L., Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998, 157:178-183.
24. Roux C., Kolta S., Desfougères J.L., Minini P., Bidat E. Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma. Pediatrics 2003, 111:e706-e713.
25. Lucas A.E., Smeenk F.W., Smeele I.J., van Schayck C.P. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 2008, 25:86-91.
26. Olszowiec-Chlebna M., Majak P., Brzozowska A., Bobrowska-Korzeniowska M., Jerzynska J., Stelmach I. Effect of inhaled steroid and montelukast on clinical symptoms in children with newly diagnosed asthma: a pilot study. Pediatr Allergy Immunol 2010, 26:687-690.
27. Bacharier L.B., Strunk R.C., Mauger D., White D., Lemanske R.F., Sorkness C.A. Classifying asthma severity in children: mismatch between symptoms, medication use, and lung function. Am J Respir Crit Care Med 2004, 170:426-432.
28. Schou A.J., Heuck C., Wolthers O.D. Does vitamin D administered to children with asthma treated with inhaled glucocorticoids affect short-term growth or bone turnover?. Pediatr Pulmonol 2003, 36:399-404.
29. Hanson D.A., Ma Weis, Bollen A.M., Maslan S.L., Singer F.R., Eyre D.R. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992, 7:1251-1258.
30. Chlebna-Sokol D. Lodz: diagnostic and treatment of osteoporosis and osteopenia in children 2002, Ankal Press. 1st ed.